Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.634
-0.015 (-2.37%)
At close: May 17, 2024, 4:00 PM
0.665
+0.031 (4.96%)
After-hours: May 17, 2024, 7:32 PM EDT
Alzamend Neuro Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Alzamend Neuro.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Alzamend Neuro.
Recommendation Trends
Rating | Feb '23 | Mar '23 | Apr '23 |
---|---|---|---|
Strong Buy | 1 | 1 | 0 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +3,451.14% | Apr 12, 2023 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $120 | Strong Buy | Initiates | $120 | +18,839.39% | Oct 1, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.55
from -2.25
EPS Next Year
-1.61
from -1.55
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | 33.1M | 139.3M | 239.9M |
Avg | n/a | n/a | n/a | 32.2M | 135.4M | 233.1M |
Low | n/a | n/a | n/a | 30.9M | 130.1M | 223.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | - | 333.0% | 77.2% |
Avg | - | - | - | - | 320.6% | 72.2% |
Low | - | - | - | - | 304.1% | 65.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.23 | -0.77 | -0.59 | -0.21 | 1.46 | 3.12 |
Avg | -1.55 | -1.61 | -0.57 | -0.20 | 1.42 | 3.03 |
Low | -1.83 | -2.37 | -0.55 | -0.20 | 1.36 | 2.91 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | - | - | 120.0% |
Avg | - | - | - | - | - | 113.7% |
Low | - | - | - | - | - | 105.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.